The Center for PhAIge Therapy combines engineering and artificial intelligence to leverage the potential of phages—viruses that naturally infect and kill bacteria—as new treatment options for these drug-resistant infections.
Despite promising results in individual patients, phage therapy has remained difficult to use at a larger scale. The new research center will build the preclinical tools and models needed to overcome this obstacle and make phages a more reliable treatment for infections.
Gladstone scientists have already built AI to predict which phages work against a given bacterial strain, but those models need far more data to be accurate. In this center, the researchers are generating an unprecedented amount of data to train the models by using engineered phages and bacteria to better understand, step by step, how bacteria are killed.
The center was launched in 2026 through an initial award of $2 million from the National Institute of Allergy and Infectious Diseases (NIAID), with additional funding of up to a total of $10 million available over the proposed 5-year project period. Gladstone is one of three institutions across the country selected to host the new Centers for Accelerating Phage Therapy to Combat ESKAPE Pathogens (CAPT-CEP) to advance the therapeutic use of phages.
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
DONATE NOW
A new discovery reveals how a SARS-CoV-2 protein reprograms immune cells to accelerate viral spread—and points to a new strategy for therapeutic intervention.
The fellowship provides three years of funding for graduate students pursuing groundbreaking immunology research.
Takahashi is recognized for his pioneering work translating iPS cell technology into a clinically approved therapy for Parkinson’s disease.
An unprecedented map of 22 million immune cells provides the functional rulebook for virtual biology and next-generation immunotherapies.
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsDiscoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreYour gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now
